Cubist Systematic Strategies’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.65M | Buy |
|
|||||
|
2025
Q1 | $4.91K | Sell |
|
|||||
|
2024
Q4 | $4.73M | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $2.79M | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $167K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $1M | Buy |
|
|||||
|
2021
Q4 | $823K | Buy |
|
|||||
|
2021
Q3 | $313K | Sell |
|
|||||
|
2021
Q2 | $363K | Buy |
|
|||||
|
2021
Q1 | $375K | Sell |
|
|||||
|
2020
Q4 | $766K | Buy |
|
|||||
|
2020
Q3 | $114K | Sell |
|
|||||
|
2020
Q2 | $229K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $17K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $16K | Sell |
|
|||||
|
2016
Q4 | $19K | Buy |
|